REPLIGEN CORP Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2013 to Q1 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Repligen Corp annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2013 to Q1 2024.
- Repligen Corp Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$1.12M, a 42.6% decline year-over-year.
- Repligen Corp annual Deferred Income Tax Expense (Benefit) for 2024 was -$16.8M, a 1529% decline from 2023.
- Repligen Corp annual Deferred Income Tax Expense (Benefit) for 2023 was $1.18M.
- Repligen Corp annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.35M, a 121% decline from 2021.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)